Medicalook
Medicalook

Cobrentin

http://www.medicalook.com
Cobrentin

Cobrentin review





Cobrentin, an anticholinergic medication, is used for treating Parkinsons illness and related conditions such as parkinsonism, dystonia, and akathasia. It is been shown to have an effective and significant therapeutic value in the management of the symptoms of parkinsonism. It counteracts the effects of the neurotransmitter acetylcholine and balances the levels of acetylcholine and dopamine in the body, which can help reduce the symptoms of Parkinson's illness in its early stages. It can also be used to treat movement disorders resulting from the use of other antipsychotic medication. Doctors have also observed an antihistaminic activity approaching that of pyrilamine maleate.

It is available as a tablet in 0.5 mg, 1 mg or 2 mg dosages and as brand names such a Cogentin.

This medication is primarily prescribed for most forms of parkinsonism and movement disorders resulting from the use of antipsychotic medicaments, with the exception of tardive dyskenesia. It can also be a useful part of Parkinson's treatment because it helps reduce symptoms of tremors rather than the stiffness of motion. Patients with dystonia also benefit from Cobrentin since it can relax the sudden contortions of the limbs and torso that these patients can suffer.

Cobrentin is administered using the lowest dosage possible, with the doctor monitoring the patient's condition as the dosage is increased by 0.5mg every 5 to 6 days, up to a maximum dosage of 6 mg. The reason is to find the optimal dosage for the patient using the least amount of medicine possible.

The doctor will typically instruct the patient to take the medicine 2 to 4 times each day along with meals and before bedtime or as a single dosage at bedtime. The doctor may modify dosage as they see fit based on the patient's condition.

Cobrentin should be taken at least an hour before taking antacids containing calcium, magnesium or aluminum. Also allow one to two hours before and after taking Cobrentin when taking adsorbent diarrhea medication containing pectin, kaolin or attapulgite as this may affect the body's absorption of Cobrentin. If you are taking ketoconazole, do not take Cobrentin until two hours after the ketoconazole dosage as it may affect the absorption of the keotconazole.

When Cobrentin is being taken to counteract side effects caused by another antipsychotic medication, your doctor may direct you to take it only as necessary. The doctor may also alter the dosage of the other medicaments you are taking. Follow the doctor's prescriptions carefully.

Though rare, an addiction may arise from the use of this medication. Do not extend your treatment or increase your dosage unless directed to do so by your doctor. Proper halting of treatment will be essential, but in certain cases an abrupt discontinuing of dosage may aggravate certain symptoms so your doctor may design an increasingly lowered dosage until you can safely stop taking this medication.

Side effects may include dizziness, costiveness, nausea, drowsiness, blurred vision or a dry mouth. The side effects may reduce as you get used to the medication, but if any of these symptoms worsen or persist, consult your doctor.

Inform your doctor immediately if you experience high fevers, severe stomach pain, any difficulty in passing urine, weakness or a decrease in sexual ability. If you feel chest pains, dizziness which results in fainting, mood swings or mental disturbances, irregular heartbeats or symptoms of extreme allergic reactions such as rashes, fever or inflammation, seek immediate medical attention.

Inform your doctor of your complete medical history, including any existing medical conditions such as heart illness, glaucoma, gastrointestinal disorders such as ulcers and blockage, liver illness, other mental and movement disorders, hypertension, or disorders causing difficulty in urination.

Cobrentin may cause drowsiness. Due to this, avoid driving or operating machinery while taking this medication. Also, avoid spending time in poorly ventilated, hot areas as some users may experience an increase in body temperature.

Cobrentin has the following structural formula:

Chemical structure of cobrentin


• Molecular formula of cobrentin is C21H25NO
• Chemical IUPAC Name is 3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane
• Molecular weight is 307.429 g/mol
Cobrentin available : 0,5mg tablets, 1mg tablets and 2mg tablets

Generic name: Benztropine

Brand name(s): Akitan, Benzatropina, Benzatropine, Benzatropinum, Benztropine mesylate, Benztropinum, Cogentin, Cogentine, Cogentinol

  Your Cobrentin review